fluvoxamine and Intracranial-Hypertension

Drug-induced intracranial hypertension is a well-established entity. We report a rare case of intracranial hypertension with papilledema in a 10-year-old boy following use of fluvoxamine, a selective serotonin reuptake inhibitor. On discontinuing the drug, the papilledema resolved over 4 months without any residual visual anomalies. To the best of our knowledge, this is the first report of fluvoxamine-induced intracranial hypertension with papilledema.

Topics: Anti-Anxiety Agents; Child; Fluvoxamine; Humans; Intracranial Hypertension; Intracranial Pressure; Magnetic Resonance Angiography; Male; Obsessive-Compulsive Disorder; Papilledema